Provenance Record

Well-structured News piece using the site's standard Overview / What We Know / What We Don't Know format. Clear, neutral, appropriately technical for the subject (gene-editing platform trials), and each subsection (program mechanics, the seven teams, the JAX/Broad award detail, program history) is cleanly sourced. Word count is 1262, slightly above the 400-1200 words documented for News in config/editorial_policy.md (the chief_editor_review.ts script itself uses a looser internal range of 200-2000 for News, so the automated checklist did not flag this). This is a minor style overage, not a factual issue, and does not warrant a corrections record or a verdict downgrade; noting it for the record and flagging the script/policy range mismatch as a separate pipeline follow-up.

All 3 sources were fetched successfully by chief:review (HTTP 200 each) and read in full from the local gzip snapshots in sources/2026-07/arpa-h-awards-160-million-to-seven-teams-to-build-scalable-gene-editing-platforms-for-rare-pediatric-diseases/ after independently verifying each snapshot's sha256 against manifest.json (all three matched). Snapshot-by-snapshot: (1) source-0.html.gz — arpa-h.gov official announcement, published July 9, 2026. Confirms the $160M/5-year commitment, the THRIVE name and full expansion, the '95% of rare diseases have no approved medicines' statistic, the Alicia Jackson and Daria Fedyukina quotes verbatim, the year-1/year-3/year-5 milestone structure, and the disease target for all seven awardee teams (CHOP, UC Berkeley/IGI, St. Jude, Broad Institute, GEMMABio/Profluent Bio, Mass General, Stanford) verbatim or near-verbatim to the article's descriptions. Also confirms the CHOP/KJ Muldoon precedent language (article correctly splits the quote around the omitted drug name 'kayjayguran abengcemeran' rather than fabricating a bridge). (2) source-1.html.gz — jax.org press release, July 9, 2026. Confirms the $34.5 million contract figure, the PERC platform name, the two initial disease targets (AHC and Dravet syndrome), the Cat Lutz and Winston Yan quotes and titles verbatim, the '12 institutions and organizations' figure, the base editing/prime editing/in vivo brain delivery description, and the Lancet Neurology statistic (roughly half of rare genetic diseases involve the CNS; 90% of rare childhood disorders have major neurological effects) verbatim and correctly attributed. (3) source-2.html.gz — Boston Globe/STAT (article correctly notes this is STAT News content republished via a Globe partnership, which the snapshot confirms in its byline note). Confirms the Fedyukina 'paradigm... treat thousands of babies' quote, the Jim Wilson/GEMMABio attribution, the KJ Muldoon 'not readily scalable... No one has said how much it cost' passage verbatim, the 2024 program origin and '100 groups applied' figures, the Mimi Lee and Renee Wegrzyn history (delay tied to the change in administrations, the nine-month leadership gap quote) verbatim, the Erik Sontheimer quotes verbatim with correct title, and the closing Fedyukina quotes verbatim. No hallucinated quotes, no misattributions, and no unsupported specifics were found across any of the three sources.

Every number, name, title, and direct quote in the article traces cleanly to one of the three cited sources; several claims (the $34.5M figure, the Jim Wilson attribution, the Lancet Neurology statistic) are correctly sourced to the specific outlet that reported them rather than conflated across sources. The 'What We Don't Know' section (undisclosed per-team funding splits beyond the JAX/Broad figure; unresolved brain/skin delivery timeline risk; unclear FDA review structure for multi-disease umbrella trials) is an accurate characterization of gaps in all three sources, not a claim of fact.

High-quality, well-sourced submission. Every quote and specific fact verified verbatim against its cited source across all three snapshots. Overriding the automated script's default APPROVE_WITH_CORRECTIONS suggestion to APPROVE, because the only flagged issue (source allowlist) is a pipeline config gap rather than a reader-facing factual problem; a corrections record would not be honest or useful to readers here. Ready for publication as-is.